1606 related articles for article (PubMed ID: 15149507)
1. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
2. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
Wasyłyszyn T; Kozłowski W; Zabielski SL
Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
[TBL] [Abstract][Full Text] [Related]
3. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
[TBL] [Abstract][Full Text] [Related]
4. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
6. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients.
Yano S; Nakamura K; Okochi H; Tamaki K
Acta Derm Venereol; 2002; 82(2):82-5. PubMed ID: 12125957
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
10. Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory.
Moed H; Boorsma DM; Tensen CP; Flier J; Jonker MJ; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Rustemeyer T; Gibbs S
J Pathol; 2004 Sep; 204(1):39-46. PubMed ID: 15307136
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
[TBL] [Abstract][Full Text] [Related]
12. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
13. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
Sato-Kawamura M; Aiba S; Tagami H
Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
[TBL] [Abstract][Full Text] [Related]
14. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence.
Man XY; Yang XH; Cai SQ; Bu ZY; Wu XJ; Lu ZF; Zheng M
Clin Exp Dermatol; 2009 Apr; 34(3):396-401. PubMed ID: 19309374
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
[TBL] [Abstract][Full Text] [Related]
17. Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone.
Freyschmidt-Paul P; Hamm H; Happle R; Hoffmann R
Eur J Dermatol; 1999 Mar; 9(2):111-4. PubMed ID: 10066958
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata: topical immunotherapy treatment with diphencyprone.
Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
[TBL] [Abstract][Full Text] [Related]
19. Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata.
Pazoki-Toroudi H; Ajami M; Babakoohi S; Khaki L; Habibey R; Akhiani M; Seirafi H; Firooz A
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):422-5. PubMed ID: 20095801
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
Ito T; Aoshima M; Ito N; Uchiyama I; Sakamoto K; Kawamura T; Yagi H; Hashizume H; Takigawa M
Arch Dermatol Res; 2009 Jun; 301(5):373-80. PubMed ID: 19301021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
